Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare. It also offers specialized therapeutic solutions for oncology, hematology, and ophthalmology, alongside diagnostic imaging equipment, contrast agents, and advanced cell and gene therapies. Bayer's Consumer Health segment provides a wide array of non-prescription (over-the-counter) medicines, medical devices, medicated skincare items, and nutritional supplements. These self-care products address diverse health needs such as dermatology, dietary support, pain relief, cardiovascular risk prevention, digestive issues, allergy management, and cold and cough symptoms. The Crop Science division supports the agricultural sector with chemical and biological crop protection products, genetically enhanced plant traits, seeds, digital farming tools, and solutions for pest and weed control. This segment also manages the breeding, propagation, production, and specialized treatment of seeds, complemented by dedicated customer service for farmers. Bayer is actively involved in numerous strategic collaborations to bolster its research and development pipeline. These partnerships include an agreement with MD Anderson Cancer Center for oncology drug development, a research and licensing deal with Dewpoint Therapeutics, Inc. focused on novel treatments for cardiovascular and gynecological diseases, and collaborations with Exscientia Ltd, Foundation Medicine Inc., Evotec AG, and Arvinas Inc. Additionally, the company maintains strategic research alliances with the University of Oxford for gynecological therapies and with Kyoto University to discover potential new drugs for pulmonary conditions. The company’s products reach a broad market through various distribution channels, including wholesale partners, independent and chain pharmacies, supermarkets, online and other retail outlets, hospitals, and direct sales to agricultural producers. Bayer Aktiengesellschaft was established in 1863 and is headquartered in Leverkusen, Germany.
The current price of BAYRY is $10.42 USD — it has decreased by -0.19% in the past 24 hours. Watch Bayer stock price performance more closely on the chart.
What is Bayer stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bayer stocks are traded under the ticker BAYRY.
Is Bayer stock price growing?▼
BAYRY stock has risen by +2.87% compared to the previous week, the month change is a -4.39% fall, over the last year Bayer has showed a +32.56% increase.
What is Bayer market cap?▼
Today Bayer has the market capitalization of 10.24B
When is the next Bayer earnings date?▼
Bayer is going to release the next earnings report on August 04, 2026.
What were Bayer earnings last quarter?▼
BAYRY earnings for the last quarter are 3.13 USD per share, whereas the estimation was 2.67 USD resulting in a +17.21% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bayer revenue for the last year?▼
Bayer revenue for the last year amounts to 105.75B USD.
What is Bayer net income for the last year?▼
BAYRY net income for the last year is -8.62B USD.
Does Bayer pay dividends?▼
Yes, BAYRY dividends are paid annual. The last dividend per share was 0.03 USD. As of today, Dividend Yield (FWD)% is 0.3%.
How many employees does Bayer have?▼
As of June 15, 2026, the company has 90,587 employees.
In which sector is Bayer located?▼
Bayer operates in the Health & Wellness sector.
When did Bayer complete a stock split?▼
The last stock split for Bayer was on September 20, 2017 with a ratio of 4:1.
Where is Bayer headquartered?▼
Bayer is headquartered in Leverkusen, United States.